GMP: Requirements for Risk Analyses in the Regulatory Submission Dossier: EMA\'s and FDA\'s Recommendations

The EMA has published a new question & answer-(Q&A) paper together with the FDA at the end of 2014. This document answers questions on detailed requirements in connection with the documents concerning regulatory submissions. Among other things it answers questions on the topic risk analysis.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny